Home > Healthcare > Medical Devices > Implantable Devices > Bioimplants Market

Bioimplants Market Size

  • Report ID: GMI4035
  • Published Date: Apr 2024
  • Report Format: PDF

Bioimplants Market Size

Bioimplants Market size in 2023 was valued at USD 132 billion and is anticipated to experience growth at a CAGR of 8.2% from 2024 to 2032. High market growth can be attributed to the increasing prevalence of chronic diseases and conditions, such as cardiovascular diseases, orthopedic disorders, and ophthalmic diseases, which require bioimplants for treatment and management.

 

Additionally, the rising geriatric population, which is more susceptible to these chronic conditions, is further driving the demand for bioimplants. Further, technological advancements in the field, such as the development of biocompatible materials and 3D printing techniques, are also fueling market growth by improving the effectiveness and lifespan of bioimplants. Moreover, the growing preference for minimally invasive surgeries, which require bioimplants for procedures like joint replacements and dental implants, is contributing to market expansion.
 

Bioimplants are medical devices that are implanted into the body to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. These implants can be made from a variety of materials, including metals, ceramics, and polymers, and they are designed to integrate with the body's tissues or perform specific functions within the body.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Bioimplants industry size was worth USD 132 billion in 2023 and is projected showcase 8.2% CAGR from 2024 to 2032, owing to the rising prevalence of chronic diseases and conditions, such as cardiovascular diseases, orthopedic disorders, and ophthalmic diseases.

The cardiovascular implants segment in the market recorded USD 47.4 billion in 2023 and is estimated to grow between 2024 and 2032, on account of the increasing prevalence of cardiovascular diseases and significant advancements in implants technology.

North America bioimplants industry was worth USD 48.6 billion in 2023 and is predicted to grow at 7.9% CAGR between 2024 and 2032, due to the presence of robust healthcare infrastructure, advanced technological innovations, and high healthcare expenditure.

Abbott Laboratories, Arthrex inc., aap Implantate AG, Biotronik SE & Co. KG, Cochlear Ltd., DePuy Synthes (Johnson & Johnson), Edwards Lifesciences Corporation, LifeNet Health, Medtronic plc, Organogenesis Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc. are some of the leading bioimplants companies worldwide.

Bioimplants Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 403
  • Countries covered: 22
  • Pages: 232
 Download Free Sample